GCC for Healthcare, pharma & life sciences
Life-sciences centers carry a validation burden that generic GCC playbooks ignore. The question is not whether the work can move, but what qualification, training and audit evidence has to move with it.
What usually drives the decision
- Clinical data management and biostatistics capacity
- Pharmacovigilance and regulatory operations scale
- Digital and data platforms for commercial and supply chain
- Quality systems support across a widening product portfolio
Work that normally travels
- Data & analytics
- Quality, compliance & regulatory operations
- Software engineering & product
- Finance & accounting
- R&D and design engineering
Work that normally stays
- Qualified person and market authorisation accountability
- Site-specific manufacturing quality decisions
- Investigator and health-authority relationships
What good looks like
- Validated systems requalified with the center in scope
- Case processing and query turnaround at or better than baseline
- First regulatory inspection passed with no critical finding
Sector constraints that decide the design
GxP and computer-system validation
Every validated system touched by the center needs requalification, role mapping and training records. Plan the validation calendar before the hiring plan.
Patient data handling
Pseudonymisation, cross-border transfer basis and retention rules decide which datasets the center can hold rather than only view.
Inspection readiness
The center becomes an inspectable site. SOPs, deviation handling and CAPA evidence must be live from day one, not at the first audit.
Operating model
Captive is the norm where GxP accountability is involved; managed or hybrid models work for non-validated digital, analytics and commercial support.
Designing it AI-native
Literature screening, case intake triage and document generation are the practical AI entry points — they change pharmacovigilance sizing materially and should be modelled before headcount is fixed.
Location notes
- Hyderabad for a mature pharma and life-sciences ecosystem
- Bengaluru and Pune for clinical data, engineering and analytics
Explore these cities
Other sector views
This output is a preliminary, model-based view generated from the information you provided. It is an input to an advisory conversation, not a substitute for legal, tax or financial advice. Start with the GCC feasibility assessment.